SARS-CoV2 – Page 45 – Communicable Diseases Research

470. Relapsing COVID-19 Pneumonia in Patients Receiving Rituximab Therapy

Poster Abstracts

Published on 2021-11-042022-10-29
Journal: Open Forum Infectious Diseases [Category] COVID-19,

[키워드] acute respiratory syndrome administration anti-CD20 Antigen B-cell B-lymphocyte case sery CD20 clinical collected Controlled convalescent plasma Convalescent plasma therapy coronavirus disease Coronavirus-2 Corticosteroid Course COVID-19 COVID-19 diagnosis COVID-19 disease death discharge disease disease severity evaluate figure hospital IgG Infection initial management median median age monoclonal antibody Patient patient population patients positive Prevent receive receiving relapsing Remdesivir reported Result retrospective risk rituximab SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV2 severe COVID-19 severity of COVID-19 table therapy virus while
[DOI] 10.1093/ofid/ofab466.669 PMC 바로가기 [Article Type] Poster Abstracts

Estimating the impact of virus testing strategies on the COVID-19 case fatality rate using fixed-effects models

고정 효과 모델을 사용한 CovID-19 사례 사망률에 대한 바이러스 테스트 전략의 영향 추정

Multicenter Study

Published on 2021-11-042022-09-01
Journal: Scientific Reports [Category] MERS, SARS, 진단,

Biometric covariates and outcome in COVID-19 patients: are we looking close enough?

Research Article

Published on 2021-11-042022-10-28
Journal: BMC Infectious Diseases [Category] COVID-19, MERS, SARS,

[키워드] adverse outcome affected age Analysis analyzed baseline Biometric covariates BMI Care cohorts Comorbidities complex complex interaction computational analysis Consensus covariate covariates COVID-19 COVID-19 disease COVID-19 patient COVID-19 patients CRP diagnostic disease enrichment analysis Evolution exhibited group heterogeneity hidden ICU Impact Interaction mechanical ventilation Mortality mortality risk non-survivor not significant observational study outcome parameter Patient patient cohort patients PCT performed reduced reported required Result risk risk factor Risk factors SARS-CoV2 severity specific disease Stage subgroup supplementary material suppress survival survivor the study group Treatment Treatment strategies
[DOI] 10.1186/s12879-021-06823-z PMC 바로가기 [Article Type] Research Article

The role of fenofibrate in the treatment of COVID-19

Short Communication

Published on 2021-11-032022-10-04
Journal: Annals of Medicine and Surgery [Category] 치료법,

[키워드] ACE Analysis caused Cell COVID-19 COVID-19 patients Effect Fenofibrate help host cell increase in Mortality pandemic Patient positive Prevent receptor reduce regimen S protein Safe SARS-CoV2 SARS-CoV2 infection severity suggested the SARS-CoV-2 virus therapeutic Treatment viral entry viral spike protein virus Wuhan, China
[DOI] 10.1016/j.amsu.2021.102974 PMC 바로가기 [Article Type] Short Communication

Vitality of Proteinase K in rRTPCR Detection of SARS-CoV2 Bypassing RNA Extraction

SARS-CoV2 우회 RNA 추출의 rRTPCR 검출에서 Proteinase K의 활력

Cellular and Infection Microbiology

Published on 2021-11-032022-09-11
Journal: Frontiers in Cellular and Infection Microbiology [Category] MERS, SARS, 치료기술,

The Role of Endothelium in COVID-19

COVID-19에서 내피의 역할

Review

Published on 2021-11-032022-09-12
Journal: International Journal of Molecular Sciences [Category] MERS, SARS, 진단,

[키워드] 2019 novel coronavirus Affect angiotensin Apoptosis cardiometabolic disease cardiometabolic diseases cardiovascular comorbidities cardiovascular comorbidity cause cell types complications Consequences Coronary artery Coronary artery disease coronavirus disease Coronavirus disease 2019 COVID-19 diabetes Diabetes Mellitus endothelial cells Endothelial dysfunction Endothelium generate global pandemic heart failure hyper inflammation hypertension hypoxia Lower respiratory tract moderate myocardial injury Non-pulmonary Novel coronavirus obesity organ Organ perfusion Pathogenesis pathogenesis of COVID-19 Patient problems procoagulant raise reduce renal renal failure renin–angiotensin system resulting risk role SARS-CoV-2 SARS-CoV2 Severe acute respiratory syndrome severity the patient thromboembolic Thromboembolic events Treatment upper and lower respiratory tracts variety viral infection virus with COVID-19
[DOI] 10.3390/ijms222111920 PMC 바로가기 [Article Type] Review

A case of myocarditis in a 60-year-old man 48 h after mRNA vaccination against SARS-CoV2

Letter to the Editors

Published on 2021-11-032022-10-31
Journal: Clinical Research in Cardiology [Category] Coronavirus, COVID19(2023년), MERS, SARS,

[키워드] 60 years old MRI mRNA mRNA vaccination mRNA-1273 myocarditis SARS-CoV2 troponin vaccination
[DOI] 10.1007/s00392-021-01946-4 PMC 바로가기 [Article Type] Letter to the Editors

Battle against the pandemic: Emergence of SARS-CoV2 variants and global challenge

전염병과의 전쟁: SARS-CoV2 변종의 출현과 세계적인 도전

Article

Published on 2021-11-012022-09-11
Journal: Travel medicine and infectious disease [Category] SARS, 변종,

[키워드] battle emergence SARS-CoV2 variant
[DOI] 10.1016/j.tmaid.2021.102173 PMC 바로가기 [Article Type] Article

Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence

Review

Published on 2021-11-012022-10-29
Journal: International Review of Cell and Molecular Biology [Category] COVID-19,

[키워드] acute phase acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome adverse event antioxidant appear ARDS cause characterized clinical trial clinical trials coronavirus coronavirus disease COVID-19 COVID-19 patients current decrease dose elevated Evidence FIVE hospital IMPROVE Infection Inflammation inflammatory markers Intervention intravenous intravenous vitamin C less Level Oxygenation parameters patients with pneumonia Pneumonia randomised controlled trial Randomised controlled trials RCT RCTs reactive oxygen specy reduce reduce mortality reported respiratory infection retrospective cohort review ROS SARS-CoV-2 SARS-CoV2 Sepsis Seven severe cases severely ill patients severity survival rate syndrome the disease Trial Upcoming Vitamin Vitamin C with COVID-19
[DOI] 10.3390/life11111166 PMC 바로가기 [Article Type] Review

Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity

Case report

Published on 2021-11-012022-10-05
Journal: Clinical Infection in Practice [Category] 변종, 치료법,